Format

Send to

Choose Destination
Biosci Biotechnol Biochem. 2019 Aug 29:1-13. doi: 10.1080/09168451.2019.1659714. [Epub ahead of print]

Berberine and palmatine inhibit the growth of human rhabdomyosarcoma cells.

Author information

1
Department of Agriculture, Graduate School of Science and Technology, Shinshu University , Nagano , Japan.
2
Department of Science and Technology, Graduate School of Medicine, Science and Technology, Shinshu University , Nagano , Japan.
3
Department of Biomolecular Innovation, Institute for Biomedical Sciences, Shinshu University , Nagano , Japan.

Abstract

A natural isoquinoline alkaloid, berberine, has been known to exhibit anti-tumor activity in various cancer cells via inducing cell cycle arrest. However, it has not been investigated whether berberine and its analogs inhibit the growth of rhabdomyosarcoma (RMS), which is the most frequent soft tissue tumor in children. The present study examined the anti-tumor effects of berberine and palmatine on expansions of three human embryonal RMS cell lines; ERMS1, KYM1, and RD. Intracellular incorporation of berberine was relatively higher than that of palmatine in every RMS cell line. Berberine significantly inhibited the cell cycle of all RMS cells at G1 phase. On the other hand, palmatine only suppressed the growth of RD cells. Both of berberine and palmatine strongly inhibited the growth of tumorsphere of RD cells in three-dimensional culture. These results indicate that berberine derivatives have the potential of anti-tumor drugs for RMS therapy. Abbreviations: ARMS: alveolar rhabdomyosarcoma; ERMS: embryonal rhabdomyosarcoma; RMS: rhabdomyosarcoma.

KEYWORDS:

Berberine; palmatine; rhabdomyosarcoma; three-dimensional culture; tumorsphere

Supplemental Content

Full text links

Icon for Taylor & Francis
Loading ...
Support Center